Admission Date:  [**2103-2-14**]              Discharge Date:   [**2103-2-28**]  Date of Birth:  [**2039-11-15**]             Sex:   M  Service: MEDICINE  Allergies: Hydralazine  Attending:[**First Name3 (LF) 477**] Chief Complaint: coffee ground emesis  Major Surgical or Invasive Procedure: EGD with stent removal and placement of two new esophageal stents  History of Present Illness:  Pt is a 63 YO M with progressive esophageal cancer on xeloda who was admitted to [**Hospital1 18**] from [**Date range (1) 17912**] for dysphagia w/course notable for distal esophageal stent placement by the ERCP team.
In the ED, he was given Protonix 40 IV once and crossmatched for blood.
Pathologically enlarged paraaortic and periportal lymph nodes identified on recent PET-CT to show increased FDG avidity consistent with pathologic involvement.
Patient initially presented with dysphagia and required a stent.
He required several units of blood and underwent second EGD and stent was retrieved and two additional esoph stents were placed.
Given patient's condition, Dr. [**Last Name (STitle) **] and his family agreed that he should not under go another EGD for stent removal.
He was placed on CMO and expired 4 am [**2103-3-1**].
4. depression/anxiety/agitation:   Initially we continued celexa and risperidal.
Medications on Admission: Senna 8.8 mg/5 mL PO BID Docusate Sodium 50 mg/5 mL PO BID Pantoprazole 40 mg PO Q24H Finasteride 5 mg PO DAILY Atorvastatin 20 mg PO DAILY Alprazolam 0.25 mg PO TID Risperidone 1 mg PO HS Citalopram 40 mg PO DAILY Fexofenadine 60 mg PO QDAY Oxycodone 10 mg PO Q4H:PRN pain OxyContin 20 mg PO twice a day   Discharge Medications: None.
